Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2017

Jan 18, 2017

35081_dirs_2017-01-18_903bc0c7-1b75-4299-8646-f1e955229eb8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2017-01-13

Reporting Person: Quertermous Thomas (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-13 Director Stock Option (right to buy) $0.92 A 267000 Acquired 2027-01-13 Common Stock (267000) Direct

Footnotes

F1: The option vests and becomes exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.